Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,508.80up ₹49.10 (1.42%)BSE ₹3,512.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.
30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50
52-week range of traded prices to 30 Oct 2026
₹2,430.00Low, 30 Oct 2025₹3,796.00High, 18 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,846 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,55826.6% delivered
Ajanta Pharma share news and announcements
812 announcements, routine notices left out, newest first. Page 15 of 17.
Dec 2011
Nov 2011
Oct 2011
31 Oct · Disclosure
Company has issued options under Employees Stock Option Scheme - 2011 (ESOS SCHEME 2011) the details of options issued are as follow: (1) Total Number of option - 30,000 shares. (2) Number of Shares covered under options - 1 share per option. (3) Exercise Period - 1year.13 Oct · Board meeting
To consider and approve, inter-alia, the Unaudited Financial Results for the second quarter ended September 30, 2011.
Sep 2011
5 Sep · Management
Ms. Madhu Verma has been appointment as Nominee Director (representing EXIM Bank) w.e.f. August 25, 2011 and Mr. Navin B. Gangawane has ceased to be the director of the company w.e.f. August 17, 2011 on account of his death.
Aug 2011
Jul 2011
28 Jul · Results
18 Jul · Board meeting
To consider and approve, inter alia, the Unaudited Financial Results for the first quarter ended June 30, 2011.
May 2011
12 May · Meeting
Equity Share Transfer Books will remain close from June 25, 2011 to July 01, 2011 (both days inclusive), for the purpose of declaration of dividend. Futher, the Annual General Meeting will be held on July 01, 2011.12 May · Dividend
Date of payment of dividend on equity shares would be on or after July 01, 2011, subject to approval of the shareholders at the forthcoming Annual General Meeting.11 May · Updates
Ajanta Pharma Limited had informed the Exchange that the Board of Directors has approved the Employee Stock Option Scheme for 1,80,000 equity shares, 1.5% of the current equity subject to the approval of the shareholders in the ensuing Annual General Meeting to be held on July 08, 2011. The Company has now informed the Exchange that inadvertently the date of the Annual General Meeting had been mentioned as July 08, 2011 instead of July 01, 2011.2 May · News Verification
News Verification : The media had reports that Dabur India Limited may acquire the company's OTC brand, 30-Plus. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ajanta Pharma Limited has vide its letter inter-alia stated, "The company is in discussion with Dabur India Limited on the matter, but nothing has been finalized yet. Further, we wish to inform you that in case of any positive development in the matter we shall forthwith inform the stock Exchange."2 May · Management
Ms. Manjiri Bhalerao, a Nominee Director of the Company representing Export Import Bank of India has resigned w.e.f. April 30, 2011 and in her place Mr. Navin Gangawane has been appointed as the new Nominee Director of the Company representing the Export Import Bank of India w.e.f. April 30, 2011.
Apr 2011
30 Apr · Disclosure
Board of Directors has approved the Employee Stock Option Scheme for 1,80,000 equity shares, 1.5% of the current equity subject to the approval of the shareholders in the ensuing Annual General Meeting to be held on July 08, 2011.30 Apr · Dividend
Board of Directors of the Company at its meeting held on April 30, 2011, have recommended the dividend @ Rs. 5/- per share, subject to the approval of the shareholders at the ensuing Annual General Meeting.19 Apr · Board meeting
To consider and approve, inter alia, the audited Financial Results for the year ended March 31, 2011 and recommending dividend, if any, on equity shares of the Company for the Financial Year 2010-11.
Jan 2011
10 Jan · Board meeting
To consider and approve, inter alia, the Unaudited Financial Results for the third quarter ended December 31, 2010.
Dec 2010
20 Dec · Change in Registrar & Share Transfer Agent
Details of the company's Registrar & Share Transfer Agents are as under: M/s. Link lntime India Private Limited (formerly M/s. Intime Spectrum Private Limited) C-13, Pannalal Silk Mill Compound, L.B.S. Marg, Bhandup (West), Mumbai - 400078.
Oct 2010
11 Oct · Board meeting
To consider and approve, inter-alia, the Unaudited Financial Results for the second quarter and half year ended September 30, 2010.
Jul 2010
19 Jul · Board meeting
To consider and approve, inter alia, the Unaudited Financial Results for the quarter ended June 30, 2010.
Jun 2010
May 2010
26 May · Updates
Date of payment of dividend on equity shares would be on or after July 9, 2010, subject to approval of the shareholders at the forthcoming Annual General Meeting.17 May · Meeting
Equity Share Transfer Books will remain close from July 01, 2010 to July 09, 2010 (both days inclusive), for the purpose of declaration of dividend. Futher, the Board has recommended dividend of Rs. 3.50/- per equity share on the face value of Rs. 10/- per share to be paid to the shareholders if the same is approved by the shareholders in the Annual General Meeting to be held on July 09, 2010.6 May · Dividend
Board of Directors, at their meeting held on May 06, 2010, have recommended the dividend @ Rs. 3.50 per share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on July 09, 2010.
Apr 2010
26 Apr · Board meeting
To consider and approve, inter alia, the audited Financial Results for the year ended March 31, 2010 and recommending dividend, if any, on equity shares of the Company for the Financial Year 2009-10.